Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer

February 13, 2023 updated by: Xijing Hospital

The goal of this observational study is to learn about in describe participant population. The main questions it aims to answer are:

  • What are the risk factors of postoperative pulmonary infection in patients with esophageal cancer？
  • Whether we could establish a clinical prediction model to provide basis for early clinical intervention or not? Participants will describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items. If there is a comparison group: Researchers will compare insert groups to see if insert effects.

Study Overview

Status

Completed

Conditions

Detailed Description

Data were collected from the electronic medical records of Xijing Hospital. Each record is entered by two team members working simultaneously to ensure data accuracy.

Study Type

Observational

Enrollment (Actual)

1688

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

From January 2016 to December 2021, patients with esophageal cancer were hospitalized for surgery in the Department of Gastroenterology, Xijing Hospital.

Description

Inclusion Criteria:

  • Diagnosis of esophageal cancer;
  • Radical resection of tumor for the first time;
  • No distant metastasis was observed in preoperative examination

Exclusion Criteria:

  • Patients with preoperative pulmonary infection or symptoms of pulmonary infection;
  • Patients with tracheal intubation assisted ventilation before surgery;
  • Patients with preoperative lung imaging changes or abnormal white blood cells in blood routine;
  • Patients undergoing emergency surgery;
  • Patients with other cancers;
  • Patients with incomplete clinical data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Infection
Patients who developed pulmonary infection after radical resection of tumor
Without infection
Patients without pulmonary infection after radical resection of tumor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pneumonia
Time Frame: A week after radical resection of tumor
Pulmonary infection in patients with esophageal cancer after radical resection of tumor
A week after radical resection of tumor

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Xijing Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

October 31, 2021

Study Completion (Actual)

January 31, 2023

Study Registration Dates

First Submitted

February 13, 2023

First Submitted That Met QC Criteria

February 13, 2023

First Posted (Estimate)

February 23, 2023

Study Record Updates

Last Update Posted (Estimate)

February 23, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • XijingHCJF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe